Randy E. Dobbs - 17 Aug 2026 Form 4 Insider Report for VIEMED HEALTHCARE, INC. (VMD)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 Aug 2026, 16:30:23 UTC
Prior SEC filing
20 Aug 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jesse Bergeron, Attorney-in-Fact

Key filing fact

Randy E. Dobbs filed Form 4 for VIEMED HEALTHCARE, INC. (VMD) on 19 Aug 2026.

Key facts

  • This page summarizes Randy E. Dobbs's Form 4 filing for VIEMED HEALTHCARE, INC. (VMD).
  • 6 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 19 Aug 2026, 16:30.

Change

  • Previous filing in this sequence was filed on 20 Aug 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001432826 Primary reporting owner

Dobbs Randy E.

Relationship
Director
Address
625 E. KALISTE SALOOM RD., LAFAYETTE
Signature
/s/ Jesse Bergeron, Attorney-in-Fact
Signature date
19 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VMD transaction

Common Shares

Options Exercise

Transaction value
Shares
+16,763
Change %
+13%
Price
Shares after
142,253
Date
19 Aug 2026
Ownership
Direct
Footnotes
F1
VMD transaction

Common Shares

Options Exercise

Transaction value
Shares
+4,191
Change %
+2.9%
Price
Shares after
146,444
Date
19 Aug 2026
Ownership
Direct
Footnotes
F2
VMD transaction

Common Shares

Disposed to Issuer

Transaction value
Shares
-4,191
Change %
-2.9%
Price
$8.94*
Shares after
142,253
Date
19 Aug 2026
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VMD transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-16,763
Change %
-100%
Price
$0.000000*
Shares after
0
Date
19 Aug 2026
Ownership
Direct
Underlying class
Common Shares
Underlying amount
16,763
Exercise price
Footnotes
F1, F4
VMD transaction Derivative

Phantom Share Units

Options Exercise

Transaction value
Shares
-4,191
Change %
-100%
Price
$0.000000*
Shares after
0
Date
19 Aug 2026
Ownership
Direct
Underlying class
Common Shares
Underlying amount
4,191
Exercise price
Footnotes
F2, F5
VMD transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares
+16,848
Change %
Price
$0.000000*
Shares after
16,848
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Shares
Underlying amount
16,848
Exercise price
Footnotes
F1, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.

Footnote F2

Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.

Footnote F3

Per share value is based on the market closing price of the common shares for August 19, 2026.

Footnote F4

On August 19, 2025, the reporting person was granted Restricted Stock Units which vest on August 19, 2026.

Footnote F5

On August 19, 2025, the reporting person was granted Phantom Share Units which vest on August 19, 2026.

Footnote F6

Restricted Stock Units (RSUs) granted to reporting person on August 17, 2026, which vest on the first anniversary of the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .